Skip to main content
INSP logo

INSP

Inspire Medical Systems, Inc.
$46.95 +1.49 (+3.28%) At close · Jul 2
Market Cap
$1.35B
Shares
28,813,153

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$46.95 Open$46.23 Day$45.72–47.71 52W$38.91–147.03 Avg vol 30d946K Short int3.6M · 12.5% float · 3.8d Short vol50% Last earningsMay 4, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 4
Equibles Rating blended score · not investment advice
Overall
Buy
Technical · trend & momentum Neutral
50 / 200-day cross no cross
Price vs 200-day avg −34% below
+ Price vs 50-day avg +4% above
RSI (14) 62 · neutral
+ MACD trend positive
52-week position 7% · near low
Sentiment · smart money Bullish
Trend (MA cross) 50d $45 › 200d $71 — 200d above 50d
+ Institutional flow 4 of 302 funds reported for Jun 30 · net +521 sh shares · +1 new
Insider flow Net -$175.9K over 90 days · 100% sells
+ Short interest 12.46% of float · ▼ -2.9% MoM · 3.8 days cover
Volume signal Volume near normal
Institution breadth 302 holders — near 3-yr low, contrarian setup
Fundamentals Excellent
+ Revenue growth +62% Y/Y
+ Gross margin 949%, contracting
+ EPS growth +179% Y/Y
+ Free cash flow $78.5M
+ Valuation P/E 10.7 · below peers
+ Buyback $100.0M remaining
+ Balance sheet net cash $80.3M

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next
Next earnings call
Aug 3, 2026 Est · unconfirmed · in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 4, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Guidance & track record
      Latest guidance · from the 8-K filed May 4, 2026
      Revenue · Full Year 2026 Initiated $825M – $875M
      prior FY $911.98M midpoint −6.8% Y/Y
      Adjusted operating margin · Full Year 2026 Initiated 2% – 4%
      Diluted EPS · Full Year 2026 Initiated $0.07 – $0.62
      prior FY $4.89 midpoint −92.9% Y/Y
      Adjusted diluted EPS · Full Year 2026 Initiated $0.75 – $1.25
      Capital expenditures · Full Year 2026 Initiated $40M – $45M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 2 · 2
      50 / 200-day cross
      no cross Neutral
      Price vs 200-day avg
      −34% below Bearish
      Price vs 50-day avg
      +4% above Bullish
      RSI (14)
      62 · neutral Neutral
      MACD trend
      positive Bullish
      52-week position
      7% · near low Bearish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $45 › 200d $71 — 200d above 50d
      Institutional flow Accumulating
      4 of 302 funds reported for Jun 30 · net +521 sh shares · +1 new
      Insider flow Distributing
      Net -$175.9K over 90 days · 100% sells
      Short interest Falling
      12.46% of float · ▼ -2.9% MoM · 3.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      302 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $39 Now $47 · 7% 52-wk high $147
      vs 200-day avg -34% vs 50-day avg +4%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      INSP
      Inspire Medical Systems, Inc.
      this stock
      $1.35B -49.1% +62.2% 10.7 12.5%
      ABT
      Abbott Laboratories
      $166.17B -23.5% +5.7% 26.7 1.3%
      SYK
      Stryker Corp
      $125.18B -6.8% +11.2% 37.8 1.6%
      MDT
      Medtronic plc
      $106.49B -12.7% +8.4% 22.3 1.4%
      BSX
      Boston Scientific Corp
      $67.09B -52.7% +5.5% 18.9 2.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      302
      % held
      116.6%
      Reported
      4 of 302
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      277
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      3.6M
      Days to cover
      3.8d
      Change
      -106.2K sh
      View
      Short Volume
      Short vol %
      50%
      As of
      Jul 2, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      486
      Value
      $21.7K
      As of
      May 22, 2026
      View
      Off-Exchange
      Off-exchange %
      37.6%
      Week of
      Jun 15, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$175.9K
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Daniel Goldman
      Amount
      $1.0K–$15.0K
      Traded
      Apr 10, 2023
      View
      Financials
      Financials
      Revenue (FY)
      $912.0M
      Net income (FY)
      $145.4M
      EPS diluted
      $4.89
      View
      Buybacks
      Authorized
      $200.0M
      Remaining
      $100.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 26, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $114.3K
      Shares
      2.6K
      Filed
      May 15, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 13, 2026
      View
      Investor Relations
      Latest news
      Correction: Inspire Medical Syste…
      Published
      Jul 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      INSP +8.1% +16.1% -50.6% +5.3% -49.1%
      SPY +1.4% -1.3% +8.0% -0.3% +9.2%
      vs SPY +6.6% +17.4% -58.6% +5.5% -58.3%

      Capital returns

      Buyback program · as of Mar 31, 2026
      Authorized
      $200.00M
      Spent (derived)
      $100.00M
      Remaining
      $100.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1609550 CUSIP 457730109 13F (30d) 6 filings 5 filers Visit website Investor relations